FC
XRAY icon

Farringdon Capital’s Dentsply Sirona XRAY Stock Holding History

Farringdon Capital’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148K Buy
+13,909
New +$152K 0.07% 172

Other funds holding XRAY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Farringdon Capital's XRAY Position: Q2 2026 in Review

Farringdon Capital opened a new position in Dentsply Sirona (XRAY) in Q2 2026: 13,909 shares worth $148K. The stake represents 0.07% of the portfolio and ranks #172 among its holdings.

373 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • Farringdon Capital held 13,909 shares of Dentsply Sirona worth $148K as of Q2 2026.
  • Dentsply Sirona was a new Farringdon Capital position in Q2 2026.
  • Dentsply Sirona made up 0.07% of Farringdon Capital's portfolio in Q2 2026, its #172 holding.
  • 373 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on Farringdon Capital's 13F filing for Q2 2026, filed 12 Aug 2026.